Human umbilical vein endothelial cells have recently been shown to respond to C5a with increases in intracellular Ca2", production of D-myo-inositol 1,4,5-triphosphate and superoxide anion generation. In the current studies, C5a has been found to cause in a time-and dose-dependent manner rapid expression of endothelial P-selectin, secretion of von Willebrand factor, and adhesiveness for human neutrophils. The effects of C5a in P-selectin expression and adhesiveness of neutrophils were similar to the effects of histamine and thrombin on endothelial cells. The adhesiveness of C5a-stimulated endothelium for neutrophils was blocked by anti-P-selectin, but not by antibodies to intercellular adhesion molecule 1, E-selectin, or CD18. A cell-based ELISA technique has confirmed upregulation of P-selectin in endothelial cells exposed to C5a. Binding of C5a to endothelial cells has been demonstrated, with molecules bound being -10% of those binding to neutrophils. By a reverse transcriptase-PCR technique, endothelial cells have been shown to contain mRNA for the C5a receptor. These data suggest that C5a may be an important inflammatory mediator for the early adhesive interactions between neutrophils and endothelial cells in the acute inflammatory response. (J. Clin.
Introduction
During acute inflammation, neutrophils first adhere to vascular endothelium and then migrate into the surrounding tissues. It has been proposed that at least three distinct steps are involved in neutrophil recruitment (1, 2) . First, there must be "activation" of the endothelium, defined as appearance of adhesionpromoting factors. A transient and reversible intermittent adhesion results in the "rolling" of unactivated neutrophils along the surface of activated endothelium. This is followed by the firm adhesion of neutrophils to endothelial cells. At some point, either before or after this adhesive interaction with the endothelium, neutrophils appear to become activated. Finally, neutro-phils migrate through endothelial cell junctions into the surrounding tissue. The initial rolling of the neutrophils along the endothelial cell surface appears to be mediated by members of the selectin family of adhesion molecules (L-, E-, and P-selectin) (3) . The /2 integrins (CDlla/CD18, CDllb/CD18, and CDllc/CD18) expressed on neutrophils are believed to mediate firm adhesion through interaction with intercellular adhesion molecules (ICAM) 1 and 2' expressed on the activated endothelium (3) . Recently it has been suggested that the next step involves interaction of neutrophils with platelet-endothelial cell adhesion factor present in basolateral junctions of endothelial cells (4, 5) . The final step, migration of the neutrophils into the area of inflammation, may be mediated by chemotactic factors such as C5a, LTB4, and platelet-activating factor (6) .
P-selectin was originally identified as an a-granule membrane protein in platelets capable of being translocated to the cell membrane after platelet activation and degranulation (7, 8) . Also, P-selectin is produced constitutively and stored intracellularly in Weibel-Palade bodies of human umbilical vein endothelial cells (HUVECs) (9, 10) . Exposure of endothelium to mediators such as thrombin, histamine, H202, or the complement membrane attack complex (C5b-C9) results in rapid upregulation of P-selectin expression on the cell surface (9, 1 1-13). Except for H202, the induced expression of P-selectin is short lived, peaking at 5-10 min and returning to basal levels within 30-60 min due, apparently, to internalization of P-selectin (11) . In the case of H202 stimulation of endothelial cells, P-selectin expression appears to be stable (12) . Unactivated human blood neutrophils adhere in a CD18-independent manner to endothelial cells stimulated under conditions known to promote P-selectin expression ( 12, (14) (15) (16) . Recent studies suggest that glycoproteins with sialylated 0-linked oligosaccharides may be the neutrophil ligands involved in P-selectin-dependent adhesion (17, 18) , although sulfated glycoproteins and glycolipids have also been identified provisionally as neutrophil "counter-receptors" for P-selectin (17) . In general, ligands for P-selectin interact in a Ca2' dependent manner with the NH2-terminal lectin binding domain of P-selectin. It has been shown that the binding of Ca2+ to the lectin binding domain results in a conformational change in P-selectin, promoting ligand recognition (19, 20) .
Previous studies in our laboratory have demonstrated that anti-P-selectin antibodies are protective in acute lung injury due to systemic complement activation after infusion of cobra venom factor into rats (21) . Injury in this model reaches a peak within 30 min, is dependent both on complement activation as well as on neutrophil-generated toxic oxygen products, and is associated with lung vascular expression of P-selectin. Antibody-induced blockade of P-selectin greatly reduces neutrophil accumulation in the lung and diminishes the intensity of injury (21) . The following in vitro studies were designed to explore further the role of the anaphylatoxin peptide C5a on P-selectin expression and function in HUVECs. C5a has been found to cause in HUVECs a rapid increase in adhesion of unactivated neutrophils to the endothelial cells. This increased adhesiveness is mediated by CSa-induced P-selectin expression on the endothelium. Evidence is also provided for binding of C5a to endothelial cells and for the presence of mRNA for CSa receptor (C5aR) in these endothelial cells.
Methods
Chemicals and reagents. Recombinant human C5a was a gift of Dr. Henry Showell (Pfizer Central Research, Groton, CT). The ED50 for the chemotactic activity of this CSa preparation was 1-5 nM. This was based on four separate determinations, using polycarbonate membranes (polyvinyl chloride-free) with 3-psm pores. Human blood neutrophil migration occurred over a 30-min period. Neutrophils were quantitated by fluoremetric analysis as recently described (22) . cDNA for human neutrophil C5aR was the gift of Drs. Craig and Norma Gerard (Children's Hospital, Boston, MA). Murine monoclonal antibodies against human P-selectin (PNB1.6 and PB1.3) were the gift of Dr. James C. Paulson (Cytel Corporation, San Diego, CA). Monoclonal antibody to human CD18 was provided by Dr. C. Wayne Smith (Baylor University, Houston, TX). The human anti-E-selectin monoclonal antibody (CL3) has been described previously (23 dilutions of human reference plasma from 2,500 to 2.4 pg vWf. The plates were washed and a peroxidase-conjugated rabbit anti-human vWf was added for 2 h. After washing, the substrate (o-phenylenediamine dihydrochloride) was added for 10 min and the reaction was quenched with 3 M sulfuric acid. Optical density was determined at 490 nm using an automated microplate reader.
CSa binding studies. Binding of C5a to neutrophils and HUVECs was performed using a silicone oil technique similar to that described previously (27) . Briefly, HUVECs were removed from tissue culture dishes using 0.02% EDTA and washed twice in binding buffer (50 mM Hepes, pH 7.4, containing 1 mM CaCl2, 5 mM MgCl2, 0.5% BSA, 10 mM glucose, 0.1% bacitracin, 1 mg/ml leupeptin, and 2 sg/ml aprotinin) (28) . 2 x 106 cells were incubated for 60 min on ice with 10 nM C5a supplemented with 0.1 nM radioiodinated C5a (-60,000 cpm) in a final volume of 300 Al. 100-yl aliquots of the cell suspension were layered on 200 ul of silicone oil in a 400-M1 polyethylene microcentrifuge tube and centrifuged for 2 min in a microfuge (Beckman Instruments, Inc., Fullerton, CA). Near the pellets, the tubes were transected with a razor blade separating the pellet containing cell-associated radioiodinated C5a from unbound C5a in the supernatant fluid. Cell-associated and free radioactivity were measured in a gamma counter and molecules of C5a bound per cell were calculated. C5a binding to neutrophils was measured in a manner similar to that used for HUVECs, with the exception that 5 x 106 neutrophils were used in the assay. Nonspecific binding to both cell types was measured in the presence of 1,000-fold excess unlabeled C5a (29) .
Detection of mRNA for the C5a receptor. Total RNA was isolated using Trizol Reagent (Gibco, Gaithersburg, MD) using 1 X 107 HUVECs (30) . mRNA from the HUVECs was subject to reverse transcription using a cDNA cycle kit ( 
Results
Histamine-induced P-selectin expression on HUVECs and increased neutrophil adhesion. HUVEC monolayers were stimulated with increasing concentrations of histamine for 5 mi, followed by immediate washing, fixation, and determination of P-selectin expression with a cell-based ELISA. As shown by the data in Fig. 1 A, a dose-dependent increase in P-selectin expression occurred after stimulation with histamine. To determine neutrophil adhesion, HUVEC monolayers were incubated for 5 min with increasing concentrations of histamine, followed by washing and addition of neutrophils. Concentrations of histamine of -0.1 mM did not promote neutrophil adhesion (Fig.  1 B) . Incubation of the endothelial cells with concentrations of histamine of 2 500 yM resulted in significant increases in neutrophil adherence, with a plateau in cell adhesion appearing between 1 and 5 mM concentrations of histamine. Upregulation of P-selectin expression after exposure of endothelial cells to 5 mM histamine was rapid, reaching a peak within 5 min, with a return toward basal levels by 30 min (Fig. 2) . Similar results have been previously reported using a direct immunochemical detection ("5I-antibody) of P-selectin expression on histaminestimulated endothelial cells (11) . Thrombin-induced P-selectin expression on HUVECs. As Histamine (mM) Figure 1 . Dose-responses for histamine stimulation of HUVEC monolayers. Cells were incubated with increasing concentrations of histamine for 5 min followed by washing. (A) Endothelial cell P-selectin expression was measured by an ELISA. (B) Human blood neutrophils were added and adhesion evaluated 30 min later. All comparisons were to non-histamine-exposed HUVECs. crease in P-selectin expression (Fig. 3) . Concentrations of thrombin of 2 0.1 U/ml resulted in significant upregulation of P-selectin on HUVECs, with a plateau between 1 and 10 U thrombin/ml. Again, these results are similar to those in which a different immunochemical analysis has been employed ( 11). CSa-induced P-selectin expression on HUVECs and increased neutrophil adhesion. HUVEC monolayers were incubated with increasing concentrations of C5a for 10 min, followed by washing and evaluation of P-selectin expression. C5a promoted a dose-dependent increase in P-selectin expression on HUVECs (Fig. 4 A) . C5a concentrations of < 25 nM did not result in increased expression, while C5a concentrations of 2 50 nM resulted in significant upregulation of P-selectin (P < 0.05). When 250 nM C5a des arg was used, the increase in P-selectin was abolished (Fig. 4 A) as was the increased cell adhesion (Fig. 4 B) . The dose response profile with neutrophil adhesion showed a similar profile (Fig. 4 B) . The relatively high concentrations of C5a required to induce endothelial cell responsiveness was not due to poor activity of the C5a prepara- (Fig.  7) . Stimulation of HUVECs with histamine (1 and 5 mM) or thrombin (10 U/ml) also resulted in increased vWf release, a finding that has been described previously (11) . P-selectin dependency ofneutrophil adherence to CSa-stimulated HUVECs. HUVEC monolayers were incubated with 250 nM C5a for 10 min, followed by washing and addition of neutrophils. Antibodies were added to the HUVEC monolayers, at a final concentration of 20 /ug/ml, followed by addition of neutrophils (which had been pretreated with blocking antibodies to FcyRH and FcyRLII). Under these conditions, anti-P-selectin antibody reduced neutrophil adhesion by 59% (P < 0.001), while antibodies to E-selectin, ICAM-1, and CD18, as well as a combination of these antibodies (at 20 ig/ml each) did not affect neutrophil binding to the HUVECs (Fig. 8 A) . To demonstrate the blocking capabilities of the antibodies to E-selectin, ICAM-1, and CD18, neutrophil adhesion was evaluated in HUVECs stimulated with 25 ng/ml TNF-a for 2 h (in the presence of 10 1ug/ml of these antibodies). Anti-E-selectin, anti-ICAM-1, and anti-CD18 antibodies all decreased significantly neutrophil binding (P < 0.001) to TNF-a-stimulated HUVECs, with a combination of these antibodies reducing neutrophil adhesion by 32% (P < 0.001) (Fig. 8 B) . These results are similar to those reported previously (25) . In contrast, anti-P-selectin did not affect neutrophil adhesion to TNF-a-stimulated HUVECs (Fig. 8 B) . Lack (Fig. 9, A and B, lane 2). PCR products from unstimulated HUVECs as well as TNF-a-or IFN--ystimulated cells each showed a band similar to neutrophil CSa receptor control at -1,000 bases using the full ORF primers and -600 bases using the partial ORF primers (Fig. 9, A 
Ccussion
,ently published data have indicated that CSa will cause lothelial cells (human umbilical vein or rat pulmonary artery lothelial cells) to activate protein kinase C and generate Do-inositol 1,4,5-triphosphate, to produce O2 and to convert kthine dehydrogenase to xanthine oxidase (32, 33) . The data the current report indicate that C5a also will cause rapid ression of P-selectin and adherence of neutrophils. It is also dent from this report that C5a causes another feature of lothelial cell activation: secretion of vWf (occurring within min). Based on the use of blocking antibodies, the adhesionrmoting process induced by endothelial cell activation with a has been shown to be P-selectin dependent. The failure of ibodies to ICAM-1 and CD18 to block this adhesion process it to block TNF-a-induced adhesiveness for neutrophils) sug-- (34) (35) (36) . The products in these preparations would likely have been C5a des arg, which, in our hands, has diminished activity for endothelial cells but is chemotactically active for neutrophils via the C5a des arg-vitamin D-binding protein complex (37, 38) . It is known that C5a des arg has 1/10 to 1/20 the chemotactic activity for human blood neutrophils compared with C5a (39) . It is also known that monocytes respond chemotactically to C5a and C5a des arg in a quantitatively similar manner (40) . On balance, it would appear that the loss of activity of C5a des arg for upregulation of endothelial P-selectin and for neutrophil adhesion of treated endothelial cell monolayers is consistent with the interpretation that C5a des arg is a poor agonist for endothelial cells when compared with C5a. It appears that assembly of C5b-C9 on the surface of the endothelial cell can result in P-selectin upregulation, although this also ultimately causes some cytotoxicity as measured by release of lactic dehydrogenase (13) . The ability of complement activation products to cause rapid upregulation of endothelial P-selectin may explain the ability of neutrophils to adhere rapidly to endothelium gests that the adhesion-promoting process can not be attributed to nonspecific binding of CSa to endothelial cells, followed by activation of neutrophils, with resultant upregulation of CD Ilb/CDl8 and cell adherence via the ICAM-l -dependent pathway.
Binding studies with`2I-C5a reveal specific binding, although the small number of binding sites (10% of the number found on human neutrophils) and problems with insufficient levels of specific radioactivity in the CSa preparations makes it difficult to obtain data sufficient for Scatchard analysis and calculation of binding affinities. Nevertheless, specific binding of CSa to HUVECs has been consistently found in our studies. The ability to demonstrate by reverse transcriptase-PCR technology the presence of mRNA for the C5aR, using probes to the C5aR of human neutrophils, strengthens the case for the presence in HUVECs of C5aR. To date, we have determined the C5aR is not upregulated in HUVECs stimulated with TNFa, IL-1/, or IFN-y (data not shown).
In earlier studies, two complement-related products have been described as being able to facilitate adhesion of neutrophils to endothelial cells. "C5a fragments" (zymosan-activated serum or a fraction thereof) were after injury, as opposed to the much slower onset of adhesion requiring upregulation of ICAM-1 and E-selectin. In preliminary experiments we have demonstrated that activation of whole human serum by cobra venom factor yields an activity that will cause upregulation of P-selectin on HUVEC (Foreman, K. E., and P. A. Ward, unpublished data). Whether this might be due to C5a des arg with its cofactor (vitamin D-binding protein [see above]), the membrane attack complex, or some other activation product remains to be determined.
Another pathway of rapid adhesion has been shown in vitro when iC3b is deposited on endothelial cells after the addition of fresh human serum to HUVECs that have been previously exposed to cobra venom factor conjugated to Ulex europaeus L In this case, neutrophil adhesion to HUVECs peaks 10-15 min after addition of the complement source, and the adhesion is blocked by the presence of antibodies to CD lb or CD18 (41) . The adhesion process has been attributed to CR3 (Mac-1 or CDllb/CDl 8) on the neutrophil.
With respect to neutrophils, C5a binds to C5aR, inducing polarization, pseudopod formation, upregulation of CDlla/ CD18, granule enzyme release, and generation of H202 and superoxide anion. Each of these effects may enhance binding, transmigration, and effector function of neutrophils recruited into an inflammatory site. In addition, C5a can bind to peripheral blood basophils, causing release of histamine from cytoplasmic granules (42) . In turn, this could also lead to upregulation of endothelial P-selectin. It can be surmised from these observations that C5a has potent agonist activities for both endothelial cells as well as for phagocytic cells and that the combination of these effector cell responses results in substantial proinflammatory outcomes. Obviously, determining which of these pathways may be involved in vivo is difficult. Nevertheless, the data suggest that C5a may play several roles in the acute inflammatory response. It may, as described in this report, cause rapid upregulation of P-selectin, facilitating the earliest steps in the adhesion process; C5a can directly activate neutrophils to cause upregulation of CDlla/CD18, facilitating adhesion of neutrophils to endothelial ICAM-1; finally C5a may be a key chemoattractant for the transmigration of neutrophils in complement-dependent inflammation.
The other dimension in neutrophil adhesion to the activated endothelium (resulting in the ultimate transmigration of neutrophils) relates to evidence that, in the adhesion-promoting process, neutrophil activation (as assessed by increased intracellular Ca2' and production of oxygen metabolites) occurs because of endothelial expression of platelet-activating factor and/or IL-8 (43, 44 
